Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) CFO Jamie Samath sold 108 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.
Jamie Samath also recently made the following trade(s):
- On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00.
- On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.89, for a total value of $145,230.41.
Intuitive Surgical Trading Down 0.7 %
NASDAQ ISRG opened at $538.55 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $552.00. The stock has a 50 day moving average of $507.94 and a 200-day moving average of $466.79. The company has a market cap of $191.82 billion, a PE ratio of 86.58, a PEG ratio of 5.28 and a beta of 1.39.
Analyst Upgrades and Downgrades
ISRG has been the subject of several research analyst reports. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Robert W. Baird boosted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Citigroup boosted their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Mizuho upped their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $526.06.
View Our Latest Analysis on ISRG
Institutional Investors Weigh In On Intuitive Surgical
A number of large investors have recently added to or reduced their stakes in ISRG. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical in the 3rd quarter valued at $558,807,000. International Assets Investment Management LLC increased its position in Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after buying an additional 1,088,415 shares during the period. FMR LLC increased its position in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB increased its position in Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares during the period. Finally, Strategic Financial Concepts LLC increased its position in Intuitive Surgical by 40,221.4% during the 2nd quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock worth $1,184,000 after buying an additional 265,461 shares during the period. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- What is the Dogs of the Dow Strategy? Overview and Examples
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Invest in the Best Canadian StocksĀ
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.